- Worldwide net sales decreased 0.7% to $763.7M (down 0.5% constant currency).
- Authorized a $500M increase to its existing share repurchase program.
- Nine-month net income reached $417.0M compared to $397.3M in the prior-year period.
Signal #150106 · SEC 8-K
$GMED SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $GMED filing catalyst
Why did $GMED trigger an AI stock catalyst alert?
$GMED triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +1.5/10). Headline: Globus Medical Reports Q3 Net Sales of $763.7M, Adds $500M to Buyback Program. Key points: - Worldwide net sales decreased 0.7% to $763.7M (down 0.5% constant currency). - Authorized a $500M increase to its existing share repurchase program. - Nine-month net income reached $417.0M compared to $397.3M in the prior-year period.
How did $GMED stock react after the SEC filing?
After the SEC 8-K for $GMED, observed market reaction: T0 price $81.52. Past moves do not guarantee future results.
Where can I get real-time $GMED SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $GMED via Telegram and the VIP Web Terminal from €10/month.